Enhabit, Inc. (NYSE:EHAB) Short Interest Up 11.2% in June

Enhabit, Inc. (NYSE:EHAB) was the recipient of a large growth in short interest in the month of June. As of June 15th, there was short interest totalling 3,380,000 shares, a growth of 11.2% from the May 31st total of 3,040,000 shares. Based on an average daily volume of 502,700 shares, the short-interest ratio is currently 6.7 days. Approximately 6.9% of the company’s shares are short sold.

Wall Street Analysts Forecast Growth

EHAB has been the topic of a number of research reports. UBS Group upgraded shares of Enhabit from a “sell” rating to a “neutral” rating and set a $9.50 target price on the stock in a report on Thursday, March 7th. SVB Leerink upgraded shares of Enhabit from an “underperform” rating to a “market perform” rating and set a $8.50 target price on the stock in a report on Tuesday, May 14th. Oppenheimer restated a “market perform” rating on shares of Enhabit in a report on Thursday, March 7th. Bank of America reduced their price objective on shares of Enhabit from $9.00 to $8.00 and set an “underperform” rating on the stock in a report on Thursday. Finally, Jefferies Financial Group lowered shares of Enhabit from a “buy” rating to a “hold” rating and reduced their price objective for the company from $14.00 to $8.75 in a report on Thursday, May 9th. One research analyst has rated the stock with a sell rating and seven have assigned a hold rating to the stock. According to data from MarketBeat.com, Enhabit has an average rating of “Hold” and a consensus target price of $9.79.

Enhabit Stock Down 1.6 %

NYSE:EHAB traded down $0.14 during midday trading on Monday, hitting $8.78. 609,735 shares of the company were exchanged, compared to its average volume of 580,004. The company has a fifty day simple moving average of $9.16 and a 200 day simple moving average of $9.85. Enhabit has a fifty-two week low of $7.12 and a fifty-two week high of $14.59. The company has a current ratio of 1.50, a quick ratio of 1.50 and a debt-to-equity ratio of 0.75. The company has a market capitalization of $440.40 million, a PE ratio of -5.29, a price-to-earnings-growth ratio of 1.43 and a beta of 1.86.

Enhabit (NYSE:EHAB) last announced its quarterly earnings results on Wednesday, May 8th. The company reported $0.07 EPS for the quarter, topping the consensus estimate of $0.05 by $0.02. Enhabit had a negative net margin of 7.95% and a positive return on equity of 1.43%. The firm had revenue of $262.40 million for the quarter, compared to analyst estimates of $268.25 million. As a group, equities analysts anticipate that Enhabit will post 0.24 earnings per share for the current fiscal year.

Insider Buying and Selling

In other Enhabit news, Director Jeffrey Bolton bought 10,000 shares of Enhabit stock in a transaction on Friday, May 17th. The shares were bought at an average cost of $8.33 per share, for a total transaction of $83,300.00. Following the acquisition, the director now directly owns 52,299 shares in the company, valued at $435,650.67. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. In the last quarter, insiders purchased 22,000 shares of company stock valued at $183,700. Company insiders own 1.90% of the company’s stock.

Institutional Investors Weigh In On Enhabit

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. Scopia Capital Management LP raised its stake in Enhabit by 9.3% during the 3rd quarter. Scopia Capital Management LP now owns 2,091,315 shares of the company’s stock worth $23,527,000 after acquiring an additional 177,400 shares in the last quarter. JANA Partners Management LP purchased a new position in Enhabit during the 3rd quarter worth $20,532,000. Schroder Investment Management Group grew its position in Enhabit by 0.8% during the 3rd quarter. Schroder Investment Management Group now owns 1,685,885 shares of the company’s stock worth $18,966,000 after purchasing an additional 13,387 shares during the last quarter. UBS Group AG grew its position in Enhabit by 2.0% during the 4th quarter. UBS Group AG now owns 1,666,362 shares of the company’s stock worth $17,247,000 after purchasing an additional 32,611 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. grew its position in Enhabit by 25.1% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 966,515 shares of the company’s stock worth $10,003,000 after purchasing an additional 193,675 shares during the last quarter.

Enhabit Company Profile

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.